SEC Form 4 · accession 0001803794-26-000002
ImageneBio, Inc. · IMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kristin Yarema
Officer — Chief Executive Officer · Director
Period of report
Jul 25, 2026
Accepted (ET)
Jul 28, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001835579
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 25, 2026 | M | 38,376 | $0.00 | A | 123,776 | D | |
| Common StockF1 | Jul 25, 2026 | J | 115,129 | $0.00 | A | 238,905 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | — | Jul 25, 2026 | M | 38,376 | D | — | — | Common Stock | 38,376 | 115,129 | D |
| Restricted Stock UnitsF2,F3 | — | Jul 25, 2026 | J | 115,129 | D | — | — | Common Stock | 115,129 | 0 | D |
Explanation of responses
- F1On July 28, 2025, the Reporting Person was granted restricted stock units ("RSUs"), which RSUs were previously reported in Table II. Effective with this filing, the Reporting Person has elected to report grants of RSUs that are settleable solely in shares of the Issuer's common stock in Table I as acquisitions of common stock, rather than in Table II as derivative securities. Previously reported unvested RSUs that had been reported in Table II are included in the amount of securities beneficially owned shown in Column 5 of Table I. The 115,129 unvested RSUs carried over from prior Table II reporting represent grant awarded on July 28, 2025 that vests on the schedule described in footnote 3. As reported in Column 9 of Table II, there are no remaining RSUs that settle in common stock.
- F2Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F3The RSUs vest over four years, with 25% of the shares subject to RSUs vesting on the one-year anniversary of the vesting commencement date and the remaining 75% of the shares vesting in equal quarterly installments over the following 12 quarterly dates.